Ildong Holdings Co., Ltd.

Research Ildong Holdings Co., Ltd. (000230.KS) on Bullrun: market cap KRW 68.20B, dividend yield 1.7%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 68.20B; dividend yield is 1.7%.

Peer valuation comparison

Latest dividend yield is 1.69% versus a Healthcare sector median of 2.4% (29.6% below).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 68.20Bn/a1.7%100

Dividend history

Latest trailing dividend snapshot: annual dividend/share 100 KRW, yield 1.7%.

About Ildong Holdings Co., Ltd.

Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the research and manufacture of health foods and ingredients;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Ildong Holdings Co., Ltd.'s market cap?

Ildong Holdings Co., Ltd.'s market capitalization is KRW 68.20B.

Does Ildong Holdings Co., Ltd. pay a dividend?

Ildong Holdings Co., Ltd. has a dividend yield of 1.7%.

What does Ildong Holdings Co., Ltd. do?

Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the research and manufacture of health foods and ingredients; and provides hyaluronic acid for use in drugs, medical devices, and cosmetics.